Abstract:ABSTRACT Previous studies have shown that the gut microbiota and its metabolites are associated with the success of organ transplantation. However, the specific changes in the gut microbiota of lung transplant patients remain unclear. Hence, this study aimed to elucidate the interplay between the gut microbiota, metabolome, and lung transplantation outcomes. Using 16S metagenomics sequencing and untargeted metabolic profiling, we conducted a comprehensive analysis of gut microbial and metabolic alterations in lung transplant recipients relative to non-transplant group. Our findings revealed the predominance of Enterococcus and Streptococcus genera within the lung transplant cohort, accompanied by the significant reduction in Bacteroides , Epulopiscium , Faecalibacterium , and Prevotella abundance. In addition, a significant reduction in ATRA (all-trans retinoic acid) levels and suppression of IgA production were observed in lung transplant recipients, which were found to be closely associated with the Enterococcus genus. It was speculated that the association might have implications for the prognosis of lung transplant patients. Notably, the differences in gut microbial composition and metabolomic profiles between successful transplant recipients and those experiencing chronic rejection were not statistically significant. These novel insights shed light on the putative implications of the gut microbiota and metabolome in shaping lung transplantation outcomes, and provide a foundation for future investigations and targeted therapeutic interventions. IMPORTANCE This study has profound implications for lung transplantation as it uncovers the important role of gut microbiota and metabolome in shaping transplantation outcomes. The identification of dominant bacterial genera, such as Enterococcus and Streptococcus , within the lung transplant cohort, along with the significant decrease in Bacteroides , Epulopiscium , Faecalibacterium , and Prevotella abundance, reveals potential microbial imbalances associated with lung transplantation. In addition, a significant reduction in ATRA (all-trans retinoic acid) levels and suppression of IgA production were observed in lung transplant recipients, which were found to be closely associated with the Enterococcus genus. It was speculated that the association might have implications for the prognosis of lung transplant patients. These findings hold immense clinical significance as they lay the groundwork for future research and targeted therapeutic interventions. Understanding the impact of the gut microbiota and metabolome on lung transplantation outcomes offers promising avenues for improving transplantation patient prognosis.

Fecal Metabolomics Reveals Distinct Profiles of Kidney Transplant Recipients and Healthy Controls

Biomarkers for Renal Transplantation: Where Are We?

Association of gut microbiota with allograft injury in kidney transplant recipients: a comparative profiling through 16S metagenomics and quantitative PCR

The Alteration human of gut microbiota and metabolites before and after renal transplantation

Unraveling Intestinal Microbial Shifts in ESRD and Kidney Transplantation: Implications for Disease-Related Dysbiosis

Early Metabolomic Profiling as a Predictor of Renal Function Six Months After Kidney Transplantation

Longitudinal non-targeted metabolomic profiling of urine samples for monitoring of kidney transplantation patients

[Gut Microbiota in Renal Transplant Recipients, Patients with Chronic Kidney Disease and Healthy Subjects].

Gut microbiota alterations in renal transplant recipients and the risk of urinary tract infection and delayed graft function: A preliminary prospective study

Associations between Kidney Disease Progression and Metabolomic Profiling in Stable Kidney Transplant Recipients—A 3 Year Follow-Up Prospective Study

Metabonomics Study of Intestinal Transplantation Using Ultrahigh-Performance Liquid Chromatography Time-of-Flight Mass Spectrometry

GC/MS-based Urine Metabolomics Analysis of Renal Allograft Recipients with Acute Rejection

Reduced immunomodulatory metabolite concentrations in peri-transplant fecal samples from heart allograft recipients

A Pilot Study of GC/MS-based Serum Metabolic Profiling of Acute Rejection in Renal Transplantation

Analysis on the change of gut microbiota and metabolome in lung transplant patients

Distinct Changes in Gut Microbiota of Patients With Kidney Graft Rejection

Assessing the Relationship Between Gut Microbiota and Posttransplant Diabetes Mellitus.

Unraveling interindividual differences and functional consequences of gut microbial metabolism of immunosuppressants

Fecal metabolite profiling identifies liver transplant recipients at risk for postoperative infection

Perspective: metabolomics has the potential to change the landscape of kidney transplantation diagnostics

Untargeted NMR-based metabolomics analysis of kidney allograft perfusates identifies a signature of delayed graft function